All companies
Waters logo
HealthcareWAT

Waters (WAT) Financial Forecast Calculator

Interactive 5-year forecast and DCF for Waters. Adjust revenue growth, gross margin, capex intensity, WACC, and terminal growth - see revenue, free cash flow, and enterprise value update in real time. Seeded from Waters’s most recent SEC filings.

Revenue FY30
$3.82B
from $2.96B
FCF FY30
$1.81B
Margin 47.4%
Enterprise value
$25.47B
8.6× LTM revenue
Equity value
$24.17B
Net debt $1.30B
Revenue & free cash flow - history and 5-year forecast
Line (area)
Bars
Historicals from SEC EDGAR (grey). Forecast years (color) update live as you move the sliders.

Assumptions

Revenue growth (annual)
5.3%
-10.0%baseline 5.3%40.0%
Gross margin
90.4%
5.0%baseline 90.4%90.0%
Capex % of revenue
5.4%
0.0%baseline 5.4%30.0%
WACC (discount rate)
9.00%
4.0%baseline 9.0%18.0%
Terminal growth
2.50%
0.0%baseline 2.5%5.0%

Need this as an Excel model?

Keep iterating on the Waters forecast in Excel. The downloadable sample has every assumption you see here plus a fully integrated income statement, balance sheet, cash flow, and debt schedule - five years of SEC historicals and live formulas in a fully editable workbook.

income_statement.xlsx
Income statement, brown brand palette
income_statement.xlsx
Income statement, green brand palette
income_statement.xlsx
Income statement, red brand palette

Frequently asked

What is Waters Corporation's primary business model and how does it generate revenue?+

Waters Corporation designs, manufactures, sells, and services analytical instruments, primarily liquid chromatography and mass spectrometry systems. The company operates a "razor and blade" business model, where instrument sales drive highly profitable, recurring revenue from precision chemistry consumables and service contracts.

What are the main segments contributing to Waters Corporation's revenue?+

Waters Corporation's revenue is primarily driven by two operating segments: Waters, which accounts for approximately 89% of revenue from liquid chromatography, mass spectrometry, and consumables, and TA, contributing about 11% from thermal analysis and rheometry. The company serves pharmaceutical, industrial, and academic end markets globally.

What is Waters Corporation's typical capital expenditure as a percentage of revenue?+

Waters Corporation's capital expenditure typically ranges from 3.0% to 4.0% of revenue. Approximately 60% of this is for maintenance, while 40% is allocated to growth initiatives like facility expansions, including precision chemistry manufacturing capacity.

What are the key revenue growth and profitability assumptions used in the Waters Corporation financial model?+

The financial model for Waters Corporation assumes a Revenue Growth rate of approximately 5.28%. Key profitability assumptions include COGS as 9.64% of Revenue, R&D as 5.96% of Revenue, and SGA as 23.03% of Revenue.

How does the Waters Corporation financial model assess equity valuation and credit profile?+

The Waters Corporation financial model is designed to evaluate the company's equity valuation and credit profile. It specifically allows an analyst to assess the accretion and leverage impact of the transformative Reverse Morris Trust merger with Becton Dickinson's Biosciences & Diagnostic Solutions business.

Can I download an Excel financial model for Waters Corporation, and what is its forecast horizon?+

Yes, an Excel financial model for Waters Corporation is available for download. This general corporate model provides a forecast horizon spanning from FY2026 through FY2030.

Have more financial modelling questions? Contact us

Go further

Build the financial model you need with Fina

Browse templates, examples, and downloadable Excel models for the analysis you are trying to build. If you can't find your model, ask Fina to build a model for your specific needs.

Start for free
Excel financial model spreadsheet preview showing Customer Rollforward
Fina interactive chat interface preview